Results 291 to 300 of about 210,353 (388)

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

open access: yesCirculation, 2011
J. Eikelboom   +15 more
semanticscholar   +1 more source

Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan

open access: yesHepatology Research, Volume 55, Issue 9, Page 1251-1262, September 2025.
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani   +2 more
wiley   +1 more source

The Safety of Apixaban Compared to Warfarin in Hospitalized Patients with Acute Kidney Injury. [PDF]

open access: yesJ Clin Med
Al Yami MS   +8 more
europepmc   +1 more source

Oesophageal ulcer caused by warfarin

open access: green, 1989
D E Loft   +3 more
openalex   +1 more source

Advances in emerging therapies 2008 [PDF]

open access: yes, 2009
Higgins, P., Lees, K.R.
core   +1 more source

HEAL‐X: A Novel Classification System for Xylazine Associated Wounds

open access: yesInternational Wound Journal, Volume 22, Issue 9, September 2025.
ABSTRACT The opioid crisis has been exacerbated by xylazine, a veterinary sedative increasingly present in illicit drugs. Xylazine causes severe skin wounds that increase the risk of morbidity. Current wound classification systems fail to address the unique features of this injury, creating a need for a tailored assessment and treatment approach.
Dante J. Terracciano   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy